Several works have reported heterogeneous T cell response in diabetic patients with COVID-19; some revealed significantly lower CD3+, CD4+, and CD8+ T cells [47,48], while others revealed decreased CD4+ T cells and increased CD8+ T cells in diabetics [49]. The gene discussed is CD4; the disease is COVID-19.